{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:29:31Z","timestamp":1776925771468,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.027","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T02:39:34Z","timestamp":1523587174000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-8650","authenticated-orcid":false,"given":"Cristina","family":"Maccallini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialucia","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ammazzalorso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Amoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Di Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuigia","family":"Fantacuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Giampietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazzareno","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.027_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/bph.12217","article-title":"Biological nitric oxide signaling: chemistry and terminology","volume":"169","author":"Heinrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.027_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2018.04.027_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4103\/1673-5374.194707","article-title":"Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders","volume":"11","author":"Maccallini","year":"2016","journal-title":"Neural Reg. Res."},{"key":"10.1016\/j.ejmech.2018.04.027_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.2014.918953","article-title":"Drugs targeting nitric oxide synthase for migraine treatment","volume":"23","author":"Barbanti","year":"2014","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2018.04.027_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1984703","article-title":"Potential of inducible nitric oxide synthase as a therapeutic target for allergen-induced airway hyperresponsiveness: a critical connection to nitric oxide levels and PARP activity","author":"Ibba","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2018.04.027_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0891-5849(02)00853-5","article-title":"Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease","volume":"33","author":"Pavlick","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2018.04.027_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12263-007-0050-5","article-title":"Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications","volume":"2","author":"Pandolfi","year":"2007","journal-title":"Genes Nutr"},{"key":"10.1016\/j.ejmech.2018.04.027_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.freeradbiomed.2014.11.012","article-title":"Cancer cell metabolism and the modulating effects of nitric oxide","volume":"79","author":"Ching","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2018.04.027_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","article-title":"The dual role of iNOS in cancer","volume":"6","author":"Vannini","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2018.04.027_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1566524011313080002","article-title":"iNOS: a potential therapeutic target for malignant glioma","volume":"13","author":"Jahani-Asl","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2018.04.027_bib11","first-page":"991","article-title":"Selective inhibition of inducible nitric oxide synthase by derivatives of acetamidine","volume":"8","author":"Maccallini","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543776.2014.979154","article-title":"Nitric oxide synthase inhibitors: a review of patents from 2011 to the present, Expert Opin","volume":"25","author":"Yang","year":"2015","journal-title":"Ther. Pat"},{"key":"10.1016\/j.ejmech.2018.04.027_bib13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ardp.201600020","article-title":"Quinazolinones, quinazolinthiones, and quinazolinimines as nitric oxide synthase inhibitors: synthetic study and biological evaluation","volume":"349","author":"Camacho","year":"2016","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2018.04.027_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573408012999151109100557","article-title":"Recent developments of amidine-like compounds as selective NOS inhibitors","volume":"12","author":"Re","year":"2016","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.ejmech.2018.04.027_bib15","doi-asserted-by":"crossref","first-page":"45818","DOI":"10.1074\/jbc.M306030200","article-title":"Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and N\u03c9-propyl-L-arg for the inducible and neuronal isoforms","volume":"278","author":"Fedorov","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1021\/jm800846u","article-title":"Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase","volume":"52","author":"Maccallini","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib17","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.bmcl.2010.09.059","article-title":"N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase","volume":"20","author":"Maccallini","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.027_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/cmdc.201100125","article-title":"Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine","volume":"6","author":"Fantacuzzi","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.04.027_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/acsmedchemlett.5b00149","article-title":"Selective acetamidine-based nitric oxide synthase inhibitors: synthesis, docking, and biological studies","volume":"6","author":"Maccallini","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.04.027_bib20","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1021\/jm030301u","article-title":"Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors","volume":"46","author":"Haitao","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/ja0445645","article-title":"Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification","volume":"127","author":"Zhu","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.027_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(96)00347-0","article-title":"Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats","volume":"309","author":"Mitolo-Chieppa","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.027_bib23","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-07-1719","article-title":"Mechanisms of chemoresistance to alkylating agents in malignant glioma","volume":"14","author":"Sarkaria","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.027_bib24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/jssc.201400059","article-title":"Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors","volume":"37","author":"Maccallini","year":"2014","journal-title":"J.\u00a0Separ. Sci."},{"key":"10.1016\/j.ejmech.2018.04.027_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/ajpheart.00092.2005","article-title":"Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production","volume":"289","author":"Potenza","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejmech.2018.04.027_bib26","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.027_bib28","series-title":"Glide, Version 7.0, Schr\u00f6dinger","year":"2013"},{"key":"10.1016\/j.ejmech.2018.04.027_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2018.04.027_bib30","series-title":"Schr\u00f6dinger Suite 2013 Protein Preparation Wizard; Epik Version 2.4, Schr\u00f6dinger, LLC, New York, NY, (2013) ; Impact Version 5.9, Schr\u00f6dinger, LLC, New York, NY, (2013); Prime Version 3.2, Schr\u00f6dinger","year":"2013"},{"key":"10.1016\/j.ejmech.2018.04.027_bib31","series-title":"MacroModel, Version 10.0, Schr\u00f6dinger","year":"2013"},{"key":"10.1016\/j.ejmech.2018.04.027_bib32","series-title":"LigPrep, Version 2.6, Schr\u00f6dinger","year":"2016"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:44:34Z","timestamp":1759326274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"alternative-id":["S0223523418303611"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.027","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}